Whole- exome sequencing was able to establish the genetic cause of IGHD but initially presented difficulties in diagnosing the genotype of CYP21A2/CYP21A1P. This report reveals the strengths and challenges of each sequencing technology and its applications. This evidence concerns the gene CYP21A1P and isolated congenital growth hormone deficiency.